Skip to Main Content

Paper Details

Neoantigen quality predicts immunoediting in survivors of pancreatic cancer.
Nature
73
2022
MHC, T cell, T cells, cancer, cancer cell populations, cancer cells, cancer clone, cancers, human, lymphocytes, mice, pancreatic cancer, pancreatic cancers, primary tumours, recurrent, recurrent tumours, tumours
Author NameAffiliation
Jayon LihmMemorial Sloan Kettering Cancer Center
Amber L JohnsThe Kinghorn Cancer Centre, Garvan Institute of Medical Research
Benjamin D GreenbaumMemorial Sloan Kettering Cancer Center
Benjamin D GreenbaumWeill Cornell Medical College
  • 1 - 4

Datasets

Release 1.2